Stockreport

Biohaven doses first subject in Phase I/II tumour treatment study [Yahoo! Finance]

Biohaven Ltd. Common Shares  (BHVN) 
Last biohaven ltd. common shares earnings: 2/25 04:45 pm Check Earnings Report
US:NYSE Investor Relations: investors.biohavenpharma.com
PDF It is a first-in-human, multicentre, open-label trial structured into two segments: a Phase I dose escalation and a multicohort Phase II dose expansion. The initial p [Read more]